Skip to main content
Gout | More than Flares

Recent News

Systemic sclerosis metanalysis of 31 studies (32,134 pts) shows malignancy risk signif increased (SIR 1.66; CI 1.32 - 2.08). Highest: esophageal, liver, cervical, lung, & Heme (SIR 3.35 - 13.95). 7.4 yr mean from SSc to CA dx. https://t.co/IhxvfkMqkf https://t.co/dTFjD4iqth
Dr. John Cush @RheumNow (  View Tweet)
"Gout, a physician's name for the rheumatism of a rich patient." — Ambrose Bierce

Dr. John Cush @RheumNow (  View Tweet)

Metanalysis of 31 studies (14,548 pts) looked at infection in idiopathic inflamm myopathy (IIMs). Infection prevalence was 24%, primarily Respiratory tract. PJP, aspergillosis, H zoster most prevalent pathogens. Risk factors: older age, male, DM, HTN,MDA5+ (OR 3.41), rapidly https://t.co/GvOvAVRkRv
Dr. John Cush @RheumNow (  View Tweet)
RheumIQ: True or False: In an international consortium of RA patients, MACE risk was significantly associated with disease activity but not ACPA positivity. Test your knowledge here: https://t.co/LATb1P18Sh https://t.co/Bs1ReJk0OY
Dr. John Cush @RheumNow (  View Tweet)
CAR-T Therapy: EULAR 2026 Conference Recap https://t.co/3CUp5MTN2Y https://t.co/agk5HNUSwg
Dr. John Cush @RheumNow (  View Tweet)
In the 60-120 days following an acute gout flare, the risk of MI nearly doubles, and the risk of stroke rises significantly. For more gout content, follow our Gout: More than Flares campaign at https://t.co/lQoiFjubZJ, https://t.co/263CS1obPf
Dr. John Cush @RheumNow (  View Tweet)
Optimize the therapies you use every day. Join leading gout experts as they discuss practical strategies for treat-to-target, adherence, and managing complex Gout patients. Drs: Ted Mikuls, Michael Pillinger, and Lisa Stamp Moderated by: Dr. Jack Cush Gain practical insights https://t.co/47NoiPR6GG
Dr. John Cush @RheumNow (  View Tweet)
Learn more about the fundamentals of CAR T-cell therapy and its investigational use in autoimmune disease. Sponsored by Bristol Myers Squibb. https://t.co/VvTOYY3tvz #CARTCellTherapy https://t.co/ESW8Z5BZSm
Dr. John Cush @RheumNow (  View Tweet)

Psoriatic Arthritis: EULAR 2026 Recap

Years of IL-17 vs. IL-23 debate in PsA finally got tested head-to-head: bimekizumab outperformed risankizumab on joint outcomes in the BE BOLD trial, while a GLP-1 combination study suggests weight and metabolic status are active drivers of PsA — not just comorbidities. This recap also digs into early signals that biologic choice may influence whether psoriasis progresses to PsA, and why some well-controlled patients are still in pain.

Read Article
Hip Replacement Advances Hip replacement surgery has been a major advance in the management of patients with hip damage and diminishing quality of life. While this review provides new information regarding a new type of hardware (end of article), lets begin with a general https://t.co/ZosOkoawiv
Dr. John Cush @RheumNow (  View Tweet)
Why Do Gout Flares Start at Night? The striking propensity for gout flares to initiate at night has been recognized for centuries. More recent epidemiological research supports this observation, indicating that the risk of a gout flare is more than twice as high in the early https://t.co/FbCUmXEl2y
Dr. John Cush @RheumNow (  View Tweet)
Rheumatoid arthritis is found in 2-3.8% of gout patients. For more gout content, follow our Gout: More than Flares campaign at https://t.co/lQoiFjubZJ, https://t.co/moAOVUJjKZ
Dr. John Cush @RheumNow (  View Tweet)
Guidelines to Spot Cancer in High Risk Dermatomyositis International guidelines can help identify dermatomyositis patients with a particularly high risk for cancer, according to a retrospective single-center U.S. study. https://t.co/h4jFi2Ph1M https://t.co/BueumKCYHY
Dr. John Cush @RheumNow (  View Tweet)
QD Clinic: Allopurinol for All Gout? Not Quite Dr. Brian Jaros, Chicago, discusses the use of allopurinol. https://t.co/XENBDqZ2Z6 https://t.co/KFTZwuYVLI
Dr. John Cush @RheumNow (  View Tweet)
QD Clinic: When There's Doubt in Gout Dr. Eric Dein discusses how imaging was used in correctly diagnosing a mid-foot symptom in gout. https://t.co/FNI6rlOz1O https://t.co/Xpw98DiEvs
Dr. John Cush @RheumNow (  View Tweet)
Gout Imaging in Care Gout is all about the crystals and the consequences of the disease are due to the inflammation they cause. Getting rid of urate crystals is the ultimate goal in gout, as we now know that it leads to the risk zero of flares and it normalizes the https://t.co/DGuiTOtQFa
Dr. John Cush @RheumNow (  View Tweet)
Saliva and Uric Acid Testing A recent report from China reaffirms the potential utility of salivary uric acid (UA) testing delivers smartphone-guided, enzyme-free gout screening at home for pennies per test. https://t.co/VtvJuPNEWA https://t.co/pdBmy5JoQd
Dr. John Cush @RheumNow (  View Tweet)
Four Things About Allopurinol Hypersensitivity Syndrome Dr. Robert Terkeltaub discusses allopurinol hypersensitivity syndrome in gout patients. https://t.co/5seiyfVLW1 https://t.co/0A1Rtk9hzS
Dr. John Cush @RheumNow (  View Tweet)
Systemic sclerosis metanalysis of 31 studies (32,134 pts) shows malignancy risk signif increased (SIR 1.66; CI 1.32 - 2.08). Highest: esophageal, liver, cervical, lung, & Heme (SIR 3.35 - 13.95). 7.4 yr mean from SSc to CA dx. https://t.co/IhxvfkMqkf https://t.co/qvxKgvBzWu
Dr. John Cush @RheumNow (  View Tweet)
×